EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Awareness, use, motivations and methods of accessing genetic testing in 2022 in the United States

Sukh Makhnoon, MinJae Lee, Tanushree Prasad, Alexa Badalamenti, Tami Gurley, Erika A Waters, Celette Sugg Skinner

Frontiers in Genetics · 08.11.2024 · 15

DOI: 10.3389/fgene.2024.1462831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 08.11.2024. Verfasst von Sukh Makhnoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, United States. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Awareness, access, and use of clinical and direct-to-consumer (DTC) genetic tests has increased in recent years with documented disparities in these services. We provide updated data on test awareness and use, and report novel data on motivations and methods for accessing genetic tests.

Methods

Nationally representative data from the 2022 Health Information National Trends Survey (HINTS 6) were used to assess awareness and use of ancestry, personal trait, specific disease, and carrier testing by sociodemographic characteristics, examine reasons for undergoing tests, and methods of accessing them.

Results

Overall, 81.4% of respondents were aware and 40.0% had undergone testing. Only 10% of tests were ordered by genetic counselors, 80% of carrier and 65% of specific disease tests were ordered by other healthcare providers. Understanding family history was the most common reason for undergoing ancestry (72.2%) or personal trait tests (64.9%) whereas reasons such as doctor’s recommendation (53%–59%), learning more about disease risk (18%–50%), and carrier testing (76%) were common for undergoing disease risk tests and carrier tests. In contrast to ancestry, personal trait, and carrier testing, there were no racial, ethnic, income, or rural/urban difference in use of specific disease risk testing.

Discussion

Diffusion of genetic tests into US society, although incremental, has made sizable increases in awareness, equitable use of specific disease tests but worsening socioeconomic inequality in DTC genetic test use. The study provides update on the state of genetic testing in the US and identifies groups that may need help accessing clinical genomic information and services.

Schlagwörter

Stichwörter der Autor:innen

DTCawarenessdirect-to-consumergenetic testingprevalencetest useuse

Autor:innen und Institutionen

  • Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, United States.
  • Department of Surgery, Washington University in St. Louis, St Louis, MO, United States.

Förderung

  • NCI NIH HHS

Zitieren

APA

Makhnoon, S., Lee, M., Prasad, T., Badalamenti, A., Gurley, T., Waters, E. A., & Skinner, C. S. (2024). Awareness, use, motivations and methods of accessing genetic testing in 2022 in the United States. Frontiers in Genetics, 15. https://doi.org/10.3389/fgene.2024.1462831

Vancouver

Makhnoon S, Lee M, Prasad T, Badalamenti A, Gurley T, Waters EA, et al. Awareness, use, motivations and methods of accessing genetic testing in 2022 in the United States. Frontiers in Genetics. 2024;15. doi:10.3389/fgene.2024.1462831

BibTeX
@article{Makhnoon2024,
  author = {Makhnoon, Sukh and Lee, MinJae and Prasad, Tanushree and Badalamenti, Alexa and Gurley, Tami and Waters, Erika A and Skinner, Celette Sugg},
  title = {Awareness, use, motivations and methods of accessing genetic testing in 2022 in the United States},
  journal = {Frontiers in Genetics},
  year = {2024},
  volume = {15},
  doi = {10.3389/fgene.2024.1462831}
}
Kostenlos starten →